🇯🇵 Japan Country × Condition
non small cell lung cancer nsclc Clinical Trials in Japan
Active clinical trials for non small cell lung cancer nsclc with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3, Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT07566052 Phase 3
Recruiting
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Enrollment
356 pts
Country
🇯🇵 Japan
Astellas Pharma Global Development,...
View Trial → NCT06943521 Phase 1, Phase 2
Recruiting
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Enrollment
27 pts
Country
🇯🇵 Japan
Tanabe Pharma America, Inc.
View Trial → Frequently Asked Questions
How many non small cell lung cancer nsclc clinical trials are active in Japan?
There are currently 2 active clinical trials for non small cell lung cancer nsclc with sites in Japan, of which 2 are actively recruiting patients.
How can I join a non small cell lung cancer nsclc clinical trial in Japan?
To join a non small cell lung cancer nsclc clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are non small cell lung cancer nsclc trials in Japan?
Active non small cell lung cancer nsclc trials in Japan span Phase 3, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology